Drug name - Auryxia

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US9328133 KERYX BIOPHARMS Ferric organic compounds, uses thereof and methods of making same
Feb, 2024

(1 year, 4 months from now)

US9757416 KERYX BIOPHARMS Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same
Feb, 2024

(1 year, 4 months from now)

US8338642 KERYX BIOPHARMS Ferric organic compounds, uses thereof and methods of making same
Feb, 2024

(1 year, 4 months from now)

US7767851 KERYX BIOPHARMS Ferric organic compounds, uses thereof and methods of making same
Feb, 2024

(1 year, 4 months from now)

CN101253186A KERYX BIOPHARMS Pharmaceutical-Grade Ferric Organic Compound, Uses Thereof And Methods Of Making Same
Feb, 2013

(9 years ago)

CN101374416A KERYX BIOPHARMS Method Of Reversing, Preventing, Delaying Or Stabilizing Soft Tissue Calcification
Mar, 2016

(6 years ago)

CN101378658A KERYX BIOPHARMS Method Of Treating Chronic Kidney Disease
Dec, 2016

(5 years ago)

CN101014618A KERYX BIOPHARMS Antigenic Oligomeric Assembling Polypeptide
Sep, 2017

(5 years ago)

CN101014618B KERYX BIOPHARMS Polypeptides For Oligomeric Assembly Of Antigens
Sep, 2017

(5 years ago)

CN1751056A KERYX BIOPHARMS Ferric Organic Compound, Its Preparation Method And Its Application
Feb, 2024

(1 year, 4 months from now)

CN100386336C KERYX BIOPHARMS Ferric Organic Compound, Its Preparation Method And Its Application
Feb, 2024

(1 year, 4 months from now)

CN105055446B KERYX BIOPHARMS Method For Reversing, Preventing, Delaying Or Stabilizing Soft Tissue Calcification
Aug, 2026

(3 years from now)

CN105055446A KERYX BIOPHARMS Method Of Reversing, Preventing, Delaying Or Stabilizing Soft Tissue Calcification
Aug, 2026

(3 years from now)

IN200500944P3 KERYX BIOPHARMS Ferric Organic Compounds, Uses Thereof And Methods Of Making Same
Feb, 2024

(1 year, 4 months from now)

IN244119B KERYX BIOPHARMS Ferric Organic Compounds, Uses Thereof And Methods Of Making Same
Feb, 2024

(1 year, 4 months from now)

EP1601680B8 KERYX BIOPHARMS Methods Of Making Ferric Organic Compounds
Feb, 2024

(1 year, 4 months from now)

EP1601680B1 KERYX BIOPHARMS Methods Of Making Ferric Organic Compounds
Feb, 2024

(1 year, 4 months from now)

EP1601680A2 KERYX BIOPHARMS Methods Of Making Ferric Organic Compounds
Feb, 2024

(1 year, 4 months from now)

EP1601680A4 KERYX BIOPHARMS Ferric Organic Compounds, Uses Thereof And Methods Of Making Same
Feb, 2024

(1 year, 4 months from now)

EP1778725A2 KERYX BIOPHARMS Polypeptides For Oligomeric Assembly Of Antigens
Jul, 2025

(2 years from now)

EP1778725B1 KERYX BIOPHARMS Polypeptides For Oligomeric Assembly Of Antigens
Jul, 2025

(2 years from now)

EP1931689A4 KERYX BIOPHARMS Pharmaceutical-Grade Ferric Organic Compounds, Uses Thereof And Methods Of Making Same
Aug, 2026

(3 years from now)

EP1931689B1 KERYX BIOPHARMS Pharmaceutical-Grade Ferric Citrate For Medical Use
Aug, 2026

(3 years from now)

EP1931689A2 KERYX BIOPHARMS Pharmaceutical-Grade Ferric Citrate For Medical Use
Aug, 2026

(3 years from now)

EP1978808A4 KERYX BIOPHARMS Method Of Reversing, Preventing, Delaying Or Stabilizing Soft Tissue Calcification
Jan, 2027

(4 years from now)

EP1978808A2 KERYX BIOPHARMS Ferric Citrate For Reversing, Preventing, Delaying Or Stabilizing Soft Tissue Calcification
Jan, 2027

(4 years from now)

EP1978807B1 KERYX BIOPHARMS Method Of Treating Chronic Kidney Disease
Jan, 2027

(4 years from now)

EP1978807A4 KERYX BIOPHARMS Method Of Treating Chronic Kidney Disease
Jan, 2027

(4 years from now)

EP1978808B1 KERYX BIOPHARMS Ferric Citrate For Reversing, Preventing, Delaying Or Stabilizing Soft Tissue Calcification
Jan, 2027

(4 years from now)

EP1978807A2 KERYX BIOPHARMS Method Of Treating Chronic Kidney Disease
Jan, 2027

(4 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9050316 KERYX BIOPHARMS Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same Feb, 2024

(1 year, 4 months from now)

US8846976 KERYX BIOPHARMS Ferric organic compounds, uses thereof and methods of making same Feb, 2024

(1 year, 4 months from now)

US8299298 KERYX BIOPHARMS Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same Feb, 2024

(1 year, 4 months from now)

US8754257 KERYX BIOPHARMS Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same Feb, 2024

(1 year, 4 months from now)

US8609896 KERYX BIOPHARMS Ferric organic compounds, uses thereof and methods of making same Feb, 2024

(1 year, 4 months from now)

US8901349 KERYX BIOPHARMS Ferric organic compounds, uses thereof and methods of making same Feb, 2024

(1 year, 4 months from now)

US8754258 KERYX BIOPHARMS Ferric organic compounds, uses thereof and methods of making same Feb, 2024

(1 year, 4 months from now)

US8093423 KERYX BIOPHARMS Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same Apr, 2026

(3 years from now)

US10300039 KERYX BIOPHARMS Ferric citrate dosage forms Jul, 2030

(7 years from now)

US9387191 KERYX BIOPHARMS Ferric citrate dosage forms Jul, 2030

(7 years from now)

Drugs and Companies using FERRIC CITRATE ingredient

Treatment: Control of serum phosphorous levels; Control of serum phosphorus levels

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 210MG IRON TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.